Versatile bifunctional PYTA derivatives for actinium-225 radiolabeling: a comparison to gold standards

22 April 2025, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We report the synthesis and evaluation of the first PYTA bifunctional chelators (BFCs) designed for actinium-225 coordination. Methods: Three PYTA bifunctional chelators, PY3A, PYTA-GA, and PYTA-PE, were synthesized. A comparative radiolabeling study with current gold standards, MacropaTM, DOTA and Crown derivatives, was performed. Conjugation to PSMA ligand and antibodies exemplified the applicability of the BFCs. In vivo evaluation investigated the biodistribution and long-term stability of radiocomplexes. Results: PYTA derivatives demonstrate excellent radiochemical properties with quantitative radiolabeling under smooth conditions (37°C, low concentration) and prolonged in vitro stability. In vivo evaluation of radioimmunoconjugates confirmed the prolonged stability of PYTA conjugates, yielding results comparable to Macropa™, while revealing clear instability of Crown derivative. Conclusion: These findings set PYTA as the next gold-standard chelator for actinium-225, comparable to Macropa™, with the advantages of easier bifunctional derivatives syntheses and greater versatility of radionuclides.

Keywords

Bifunctional chelator
Actinium-225
radiochemistry
alpha emitter
targeted alpha therapy

Supplementary materials

Title
Description
Actions
Title
Supporting information
Description
Materials and methods, additional figures
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.